Doctor Visit Checklist for Kidney Health

A doctor visit checklist for kidney health transforms a routine nephrology appointment from a passive update session into a productive, bidirectional clinical conversation — one where the patient arrives prepared, asks specific questions, understands the answers, and leaves with an actionable plan. Nephrology appointments are typically 20–30 minutes, often occur every three to six months, and are the primary mechanism through which CKD management decisions are made, adjusted, and communicated. How a patient uses those 20–30 minutes directly affects the quality of their care. Patients who arrive with organized records, prepared questions, and a clear sense of what they want to discuss get substantially more out of their appointments than patients who arrive without preparation and rely on the care team to drive the agenda. This article provides a complete appointment preparation framework — what to bring, what to review beforehand, what to ask, and what to confirm before leaving — that applies at every CKD stage and every type of kidney-related appointment. For the home monitoring records that feed into this checklist, see the articles on home kidney health monitoring: what to track, the blood pressure log for kidney health, and the medication list template for kidney care. For understanding what the lab results the appointment will discuss actually mean, see kidney function tests: a simple guide.

Before the Appointment: What to Prepare and Organize

The most important work in appointment preparation happens in the days before the visit — gathering records, reviewing trends, and formulating specific questions. Arriving five minutes before a scheduled 20-minute appointment with no preparation leaves essentially no time for review; spending 20–30 minutes the day before can double the productivity of the appointment itself. Gather recent lab results: pull the most recent lab results from the patient portal or print them from the most recent lab visit. Key values to identify and note before the appointment: creatinine and eGFR (are they stable, improving, or declining compared to the prior measurement?); urine albumin-to-creatinine ratio (ACR) or urine protein — any change in proteinuria is clinically significant; serum potassium, sodium, bicarbonate, phosphorus, calcium — note any values outside the reference range with the date; hemoglobin (for anemia of CKD); and parathyroid hormone if checked (relevant for mineral metabolism management). For patients who are not sure how to interpret their results, the articles on what is eGFR, creatinine blood test explained, and albumin-to-creatinine ratio: what adults should know provide accessible explanations. Prepare the home monitoring records: compile the blood pressure log for the period since the last appointment (or the most recent 4–8 weeks), highlighting the average morning and evening readings, any notable spikes, and any trends. Prepare daily weight data if tracked. Note any significant symptom changes or new symptoms since the last appointment. Update the medication list: confirm that the medication list is current — every addition, dose change, and discontinuation since the last appointment should be reflected. Add any supplements or OTC medications started since the prior visit. Print a current copy or confirm that the digital version reflects the most recent state. Write down specific questions: write two to five specific questions before the appointment rather than trying to think of them in the room. Patients who have questions written down ask them; patients who plan to remember their questions typically forget half of them once in the appointment. Good questions are specific and answerable: “My eGFR dropped from 42 to 38 since the last appointment — is this within the expected variation range or is this a meaningful change?” is a better question than “Is my kidney disease getting worse?” The NIDDK guidance on working with your care team in CKD is at the NIDDK CKD management page.

During the Appointment: Core Questions to Ask at Every Kidney Visit

Certain questions are relevant at every nephrology appointment regardless of the specific management focus at that visit. Having these questions as a standing list in the appointment checklist ensures that core monitoring and management areas are reviewed systematically even when the appointment is dominated by a specific new issue. “What are my current eGFR and creatinine, and how have they trended?” This is the foundational question of every nephrology visit. The nephrologist should be able to answer this with the specific numbers and their trend direction. Understanding whether kidney function is stable, declining slowly, or declining more rapidly than expected guides every other management decision. “Is my blood pressure at target, and does my home log show that target is being met consistently?” Presenting the home blood pressure log and asking this question specifically — rather than relying on the office blood pressure reading alone — ensures that the care team evaluates real-world blood pressure control, not just a single office measurement. “Are there any medication dose adjustments needed based on my current kidney function?” GFR-based dose adjustments are necessary for many CKD medications as the disease progresses. Asking this question at each visit prompts a systematic review that might otherwise be missed between appointments when medications have been on stable doses for months. “Are there any lab values I should be watching between now and the next appointment, and what should prompt me to call sooner?” This question identifies the specific warning signs relevant to the current clinical situation — not generic CKD warning signs, but the specific values (potassium creeping up, hemoglobin trending down, eGFR changing) that the care team is watching at this particular stage of management. “When is my next appointment, and what labs should I get before it?” Clarifying the follow-up interval and the specific lab panel before leaving the appointment prevents the gap between “when do I need to be seen?” and “when did I actually schedule?” that commonly results in longer-than-intended intervals between evaluations. “Is there anything I can do to slow progression at my current CKD stage?” This question keeps the conversation oriented toward actionable lifestyle and treatment factors — blood pressure control, protein intake, dietary sodium, blood sugar management in diabetes, smoking cessation — that have documented impact on CKD progression rate. The NKF patient resource on CKD monitoring and management is at the NKF CKD patient resource page. The KDIGO guidelines on CKD monitoring frequency and targets are at the KDIGO CKD evaluation and management guidelines.

After the Appointment: Recording Decisions and Following Through

The end of a nephrology appointment is the beginning of the implementation period — the time between now and the next scheduled visit during which the plan discussed in the appointment must be executed. Capturing the key decisions, recommendations, and follow-up items before leaving the appointment (or immediately afterward) prevents the common situation of leaving with a clear sense of what was discussed and arriving home unsure of the specific details. Capture the key decisions before leaving: write down or type immediately after the appointment: current eGFR and creatinine; any medication changes (what was added, stopped, or adjusted, and the new dose); specific dietary or lifestyle recommendations made; any referrals to other specialists or new tests ordered; and the date and type of the next appointment and its associated lab panel. If using a patient portal, many of these details will appear in the after-visit summary — review it before closing the portal to catch any discrepancies between what was discussed and what was documented. Resolve any confusion immediately: if anything in the appointment was unclear — a new medication was added and the patient is not sure what it is for, a lab result was discussed and the patient doesn’t understand the significance — ask for clarification before leaving. A brief question to the medical assistant, the nurse, or a call to the practice’s nurse advice line on the same day is easier than trying to reconstruct the conversation three days later. Update the medication list: if any medication changes were made, update the medication list before the next day. This is the single most common maintenance step that gets deferred and then missed. Schedule the follow-up before leaving the office: before leaving the practice, either schedule the next appointment directly or confirm the time interval so that it can be scheduled promptly. CKD patients with active management changes (new medication, dose adjustment, concerning lab trend) are typically seen in 4–8 weeks; stable CKD patients may be seen every 3–6 months. Leaving without scheduling creates a gap. Track lab results as they come in: any labs ordered at the appointment should be added to the personal lab tracking record when results arrive. Comparing the new results to the prior results — and to the targets the care team mentioned at the appointment — closes the feedback loop and identifies anything that needs follow-up contact between appointments. The StatPearls clinical reference on CKD management and monitoring is at the StatPearls CKD reference. For patients building a comprehensive long-term management structure that encompasses appointment preparation, home monitoring, and medication management, the article on long-term kidney care plan provides the organizing framework. For the targeted questions specifically relevant to the CKD diagnosis conversation, the companion article on questions to ask about chronic kidney disease provides a more detailed question framework for the diagnostic and staging conversations that define early CKD management.

Sources: NIDDK CKD Management · National Kidney Foundation · KDIGO CKD Guidelines · StatPearls: CKD Management

What to Bring: The Complete Appointment Preparation Package

The physical and digital materials a patient brings to a nephrology appointment determine what can actually be reviewed and discussed at that visit. A care team cannot review home blood pressure data that wasn’t brought; a medication interaction cannot be evaluated using a list that was last updated six months ago; a lab trend cannot be discussed if only the most recent value is available and the prior measurements weren’t brought for comparison. The appointment preparation package for a kidney health visit has four components, each of which contributes something the care team cannot easily reconstruct from clinical records alone. Lab results with trend data: the most recent comprehensive metabolic panel results, including creatinine, eGFR, electrolytes, and any kidney-specific markers such as ACR or urine protein. If results are available through a patient portal, print the most recent two to three panels so the care team can see the trend, not just the current number. A single eGFR of 44 means something different when the prior two readings were 48 and 46 (slow decline) versus 44 and 44 (stable) versus 52 and 48 (accelerating decline) — the trend is the clinical information. Home blood pressure log: a complete log of morning and evening blood pressure readings for the past four to eight weeks, with the date, time, position, arm, and any context notes (medication missed, unusually high salt day, significant stress). Office blood pressure readings are subject to white-coat effect, physical activity before the reading, arm position, and measurement technique — they are useful but represent a single moment. A home log with 56–112 readings over four weeks represents the real distribution of blood pressure over time and is substantially more clinically useful for evaluating whether the treatment target is being met consistently. Current medication list: a printed or digital copy of the complete current medication list, updated to reflect any changes since the last appointment. Every prescription medication, every OTC medication taken regularly, and every supplement, herbal product, or sports nutrition product belongs on the list. A dose change not reflected on the list creates the possibility of the care team recommending a further adjustment that has already been made. Written questions: two to five specific, written questions prepared before the appointment. The questions that matter most are the ones about specific results, specific management decisions, and specific next steps — not general anxiety about the disease. “Is my eGFR of 38 stable relative to where it was a year ago?” is a specific question the care team can answer with data. “Am I going to need dialysis?” is a question that requires a probabilistic answer based on progression rate, which the care team can address more specifically and usefully if the prior question was asked first and the trajectory established. Having questions written down also prevents the situation — familiar to almost every CKD patient — of leaving the appointment and then remembering the important question on the drive home.

How to Use Lab Results Before the Appointment: A Self-Review Framework

Reviewing lab results before the appointment allows patients to arrive with context and specific questions, rather than hearing the numbers for the first time during a 20-minute visit. This review does not require clinical expertise — it requires a systematic approach to comparing the current numbers with prior numbers, identifying values outside the reference range, and noting changes that are large enough to warrant a question. The following framework applies to the standard CKD lab panel that most nephrology patients have drawn before appointments. eGFR comparison: compare the current eGFR to the two or three most recent prior eGFR values. Is the trend stable (within 3–4 points of variation between readings)? Declining slowly (decreasing by 2–5 points per year)? Declining more rapidly? The KDIGO guideline threshold for “rapid progression” is a decline of more than 5 mL/min/1.73m² per year — for a patient seen every six months, a change of more than 2.5 points per visit merits a question. Creatinine comparison: creatinine moves inversely to eGFR — a rising creatinine means declining function. Note whether creatinine has increased, decreased, or held stable. For patients who know their individual creatinine baseline (their “normal” creatinine when kidney function is stable), a value above that baseline is the first indicator of a change worth discussing. Potassium: the normal range is 3.5–5.0 mEq/L in most labs. CKD patients are at risk for hyperkalemia (high potassium) because the kidneys are the primary mechanism for potassium clearance. A potassium above 5.0 in a CKD patient on an ACE inhibitor or ARB, or on a potassium-sparing diuretic, is a result that should prompt a question about whether a dietary adjustment or medication change is needed. Bicarbonate (CO2): the normal range is 22–29 mEq/L. CKD causes metabolic acidosis, which appears as a low bicarbonate. A bicarbonate below 22 — especially a trend of readings below 22 — is associated with faster CKD progression and may prompt a discussion about bicarbonate supplementation. Phosphorus: normal is 2.5–4.5 mg/dL. Elevated phosphorus in CKD is associated with cardiovascular complications and is typically managed with dietary phosphate restriction and sometimes phosphate binders. A phosphorus above the reference range or trending upward is worth a specific question about whether dietary or medication management needs adjustment. Albumin-to-creatinine ratio (ACR) or urine protein: proteinuria is one of the strongest predictors of CKD progression and cardiovascular risk. ACR is classified as normal (<30 mg/g), moderately increased (30–300 mg/g, formerly "microalbuminuria"), and severely increased (>300 mg/g, formerly “macroalbuminuria” or “overt proteinuria”). Any increase in ACR from the prior reading — even within the same category — is clinically meaningful and worth a specific question. For patients who want a detailed explanation of what ACR means and how to interpret changes over time, the article on albumin-to-creatinine ratio: what adults should know covers the clinical significance in detail. The KDIGO guidelines section on CKD evaluation and management, at the KDIGO CKD evaluation and management page, provides the clinical framework that nephrologists use to interpret these values and determine monitoring frequency. Arriving at an appointment having reviewed the most recent lab panel with this framework does not replace the care team’s interpretation — it allows the patient to ask more specific questions and understand the answers more fully.

Communicating Effectively During the Appointment

The quality of a nephrology appointment depends not only on what a patient brings but on how the conversation is conducted during the visit. Nephrology appointments move quickly because there is a great deal of clinical ground to cover in 20–30 minutes. Several communication practices allow patients to get more out of the conversation without requiring more time. Lead with the most important issue: if there is one specific concern that drove the preparation for this appointment — a notable eGFR change, a new symptom, a medication side effect that has been problematic — mention it early rather than saving it for the end. Nephrologists typically follow a systematic review pattern that covers labs, medications, blood pressure, and symptoms in sequence. A concern raised in the last two minutes of a 20-minute appointment may not receive the clinical attention it would have received if raised at the start. Use specific numbers when asking questions: “my potassium was 5.3 at the last lab” is a better question prompt than “my potassium was high.” Specific numbers allow the care team to respond with specific clinical context — whether 5.3 is within an acceptable range for a patient on RAAS blockade, whether it represents a change from the prior reading, and whether any adjustment is needed. General descriptions (“high,” “low,” “a little elevated”) invite general answers; specific values invite specific clinical responses. Ask for confirmation of understanding: after any new medication or dose change is explained, repeating the key information back to the care team (“so I’m stopping the amlodipine and starting the nifedipine extended-release at 30mg once daily — is that right?”) confirms that the instruction was heard correctly and gives the care team the opportunity to correct any misunderstanding before the patient leaves the office. This is especially important for medication changes, which have a higher cost of miscommunication than most other appointment outcomes. Ask about the “so what”: when a lab result is discussed, the clinically useful response for a patient is not just the number but what it means for management. If the nephrologist says “your phosphorus is 5.2,” the follow-up question “does that change anything about my diet or medications?” converts a data point into an action item. Confirm the follow-up plan before leaving: before leaving the room, confirm the specific next steps — what follow-up labs are ordered, when they should be done (before the next appointment, in a specific number of weeks), when the next appointment should be, and whether any referrals are pending. This takes 60–90 seconds and prevents the ambiguity that commonly leads to deferred scheduling and missed follow-up. Bring a support person when possible: patients who bring a family member, partner, or trusted friend to appointments retain more of what was discussed, catch information they misheard, and have someone to help with the post-appointment action items. This is particularly valuable for appointments where significant new information is likely — a change in CKD stage, a new medication, a referral to a specialist. Two sets of ears and one set of notes produce a more complete record of the appointment than one set of ears alone, especially in appointments where the emotional weight of the discussion makes exact recall difficult. The NKF patient education resources, available at the NKF CKD patient resource page, include guidance on preparing for specialist appointments and communicating effectively with the care team. Take notes: writing down the key points during the appointment — or immediately after, before leaving the parking lot — substantially improves what is retained. Appointment notes don’t need to be comprehensive; they need to capture the specific numbers mentioned, any medication changes, any action items before the next visit, and the date of the next appointment. A note taken immediately after an appointment is worth more than a note written that evening from memory.

Appointment Preparation as a Long-Term Management Practice

The appointment preparation checklist is most effective when it is treated as an ongoing practice rather than a one-time preparation effort. CKD is a long-term condition that is managed across dozens of appointments over years or decades. The quality of that management depends on the cumulative data — the trend in eGFR over two years, the blood pressure control pattern across 18 months of home monitoring, the medication history that explains why the current regimen was chosen — that only exists if it has been systematically collected and organized. Build and maintain a CKD management record: a single document or folder that contains the lab result history, blood pressure log, medication list with date-stamped changes, a summary of each appointment, and the key decisions made and pending at each visit creates a longitudinal record that no electronic health record system provides in a patient-accessible form. The EHR contains the clinical notes; the patient-maintained record contains the patient’s interpretation, questions, and action items. Both are necessary. Review the record before each appointment: before preparing for a new appointment, reviewing the summary from the prior appointment — what was discussed, what was decided, what action items were identified — ensures that follow-through can be confirmed and any deferred items can be raised if they haven’t been resolved. This prevents the situation where a management decision discussed at one appointment simply doesn’t appear at subsequent appointments because neither the patient nor the care team raised it. Update the record after each appointment: within 24 hours of each appointment, update the CKD management record with the current eGFR and creatinine, any medication changes, the next appointment date, and any labs ordered. This 10-minute update preserves the longitudinal record that becomes increasingly valuable as CKD progresses and the clinical history becomes more complex. Use the checklist as a teaching tool: for patients who are newly diagnosed with CKD, have recently transitioned from a primary care nephrologist to a specialty nephrologist, or have a family member or caregiver who is new to the management process, the appointment checklist provides a concrete framework for understanding what the appointments are designed to accomplish and how to participate actively in them. New patients who understand the appointment structure and the purpose of the standard monitoring parameters are better positioned to engage meaningfully with the care team from the first visit. For patients building the broader management infrastructure that surrounds appointment preparation — home monitoring, medication management, lab tracking, long-term planning — the article on long-term kidney care plan provides the organizing framework that integrates these components into a coherent patient-managed system. The NIDDK guidance on managing CKD, at the NIDDK CKD management page, provides the clinical context for understanding what the care team is managing and why each component of the monitoring and treatment plan exists. Understanding the clinical purpose behind the appointment structure allows patients to participate in their appointments as informed partners rather than passive recipients of medical decisions made without their input.